Skip to main content
SpringerLink
Log in

A Schema for Effective Osteoporosis Management

Outcomes of the Geisinger Health System Osteoporosis Program

  • Commentary
  • Published:
Disease Management & Health Outcomes

Abstract

A disconnection exists between our understanding of osteoporosis diagnosis/treatment and our ability to provide optimal bone healthcare in an organized fashion. This disconnection results, in part, from problems in inertia (moving forward with the attitude that osteoporosis is a disease worthy of management), direction (focusing on the ultimate goal of osteoporosis diagnosis and management, i.e. reduction in fracture), and flow (making it easy to do the right thing, i.e. taking the best available science, mixing it with expert opinion, and developing a program that allows all of the participants [physicians, allied healthcare providers, patients, insurers] to play a role).

The Geisinger Osteoporosis Program, developed by the Geisinger Clinic of the Geisinger Health System in Danville, Pennsylvania, USA, combines elements of healthcare provider education, patient empowerment, and access to bone density testing and outcomes assessment to achieve the outcomes of fracture reduction in a cost-effective fashion.

The healthcare provider education component includes guidelines that are data driven yet easy to navigate in an electronic milieu, combined with numerous educational opportunities. The patient empowerment component includes a ‘train the trainer’ process, whereby allied healthcare providers were taught to teach people in the community about improving their bone health and seeking osteoporosis testing where appropriate.

The bone density testing component combines peripheral technology (heel ultrasound) with central gold-standard technology (dual energy x-ray absorptiometry [DXA] of the hip and spine) to provide access to technology for rural patients. A mobile DXA unit provides central DXA scanning at the convenience of the primary care physician’s office.

Outcome measures from this program show increases in osteoporosis diagnosis, bone density testing, and prescription medication usage. A significant decrease in hip fracture was demonstrated, along with a reduction in costs based on a cost predictive model over a 5-year period.

The Geisinger program has attempted to overcome some of the problems surrounding inertia, direction and flow in the management of osteoporosis by providing the following: clinical care pathways/guidelines that are simple, specific to patients and focus on care; consistent and integrative reports of bone density; getting primary care physicians engaged in the program; and making bone density testing as well as resources and expertise readily available. Using the Geisinger program as an example and applying it to the proper group of individuals, while having an investment in time and a commitment to improvement, physicians can help to move patients forward in maintaining healthy bones.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Notes

  1. Use of tradenames is for product identification purposes only and does not imply endorsement.

References

  1. Discher CL, Klein D, Pierce L, et al. Heart failure disease management: impact on hospital care, length of stay, and reimbursement. Congest Heart Fail 2003; 9: 77–83

    Article  PubMed  Google Scholar 

  2. Rothman R, Malone R, Bryant B, et al. Pharmacist-led, primary care-based disease management improves hemoglobin A 1c in high-risk patients with diabetes. Am J Med Qual 2003; 18: 51–8

    Article  PubMed  Google Scholar 

  3. Georgiou A, Buchner DA, Ershoff DH, et al. The impact of a large-scale population-based asthma management program on pediatric asthma patients and their caregivers. Ann Allergy Asthma Immunol 2003; 90: 308–15

    Article  PubMed  Google Scholar 

  4. Ross PD. Osteoporosis: frequency, consequences, and risk factors. Arch Intern Med 1996; 156: 1399–411

    Article  PubMed  CAS  Google Scholar 

  5. Lindsay R, Meunier PJ. Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost effectiveness analysis: the basis for a guideline for the medical management of osteoporosis. Osteoporos Int 1998; 8 Suppl. 4: 1–88

    Google Scholar 

  6. Ray NF, Chan JK, Thamer M, et al. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 1997; 12: 24–35

    Article  PubMed  CAS  Google Scholar 

  7. Newman ED, Ayoub WT, Starkey RH, et al. Osteoporosis disease management in a rural health care population: hip fracture reduction and reduced costs in postmenopausal women after 5 years. Osteoporos Int 2003; 14: 146–51

    PubMed  CAS  Google Scholar 

  8. Newman ED, Hanus P. Improved bone health behavior using community pharmacists as educators: the Geisinger Health System Community Pharmacist Osteoporosis Education Program. Dis Manage Health Outcomes 2001; 9: 329–35

    Article  Google Scholar 

  9. Kanis JA, Delmas P, Burckhardt P, et al. Guidelines for the diagnosis and management of osteoporosis. Osteoporos Int 1997; 7: 390–406

    Article  PubMed  CAS  Google Scholar 

  10. Scheiber LB, Torregrosa L. Evaluation and treatment of postmenopausal osteoporosis. Semin Arthritis Rheum 1998; 27: 245–61

    Article  PubMed  Google Scholar 

  11. Meunier PJ, Delmas PD, Eastell R, et al. Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. Clin Ther 1999; 21: 1025–44

    Article  PubMed  CAS  Google Scholar 

  12. Compston J. Prevention and treatment of osteoporosis: clinical guidelines and new evidence. J R Coll Physicians Lond 2000; 34: 518–21

    PubMed  CAS  Google Scholar 

  13. Sambrook P, O’Neill S, Diamond T, et al. Postmenopausal osteoporosis treatment guidelines. Aust Fam Physician 2000; 29: 751–8

    PubMed  CAS  Google Scholar 

  14. Hodgson SF, Watts NB, Bilezikian JP, et al. American Association of Clinical Endocrinologists 2001 medical guidelines for clinical practice for the prevention and management of postmenopausal osteoporosis. Endocr Pract 2001; 7: 294–312

    Google Scholar 

  15. Brown JP, Josse RG. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 2002; 167(10 Suppl.): S1–34

    PubMed  Google Scholar 

  16. Sledar SJ, Hess M. Implementation of a drug-use and disease-state management program. Am J Health Syst Pharm 2000; 57 Suppl. 4: S23–9

    Google Scholar 

  17. Taft LB, Looker PA, Cella D. Osteoporosis: a disease management opportunity. Orthop Nurs 2000; 19: 67–76

    Article  PubMed  CAS  Google Scholar 

  18. Kanis JA, Gluer CC. An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation. Osteoporos Int 2000; 11: 192–202

    Article  PubMed  CAS  Google Scholar 

  19. Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002; 359: 1929–36

    Article  PubMed  Google Scholar 

  20. Dawson-Hughes B, Dallai GE, Krall EA, et al. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 1990; 323: 878–83

    Article  PubMed  CAS  Google Scholar 

  21. Dawson-Hughes B, Dallai GE, Krall EA, et al. Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Ann Intern Med 1991; 115: 505–12

    PubMed  CAS  Google Scholar 

  22. Black DM, Thompson DE, Bauer DC, et al. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. J Clin Endocrinol Metab 2000; 85: 4118–24

    Article  PubMed  CAS  Google Scholar 

  23. McClung MR, Geusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 2001; 344: 333–40

    Article  PubMed  CAS  Google Scholar 

  24. Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. JAMA 1999; 282: 637–45

    Article  PubMed  CAS  Google Scholar 

  25. Ammann P, Rizzoli R. Bone strength and its determinants. Osteoporos Int 2003; 14 Suppl. 3: S13–8

    PubMed  Google Scholar 

  26. Chestnut CH, Silverman S, Andriano K, et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the Prevent Recurrence of Osteoporotic Fractures Study. Am J Med 2000; 109: 267–76

    Article  Google Scholar 

  27. Hauselmann HJ, Rizzoli R. A comprehensive review of treatments for postmenopausal osteoporosis. Osteoporos Int 2003; 14: 2–12

    Article  PubMed  CAS  Google Scholar 

  28. Lydick E, Cook K, Turpin J, et al. Development and validation of a simple questionnaire to facilitate identification of women likely to have low bone density. Am J Manag Care 1998; 4: 37–48

    PubMed  CAS  Google Scholar 

  29. Black DM, Steinbuch M, Palermo L, et al. An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int 2001; 12: 519–28

    Article  PubMed  CAS  Google Scholar 

  30. Siris ES, Miller PD, Barrett-Connor E, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results form the National Osteoporosis Risk Assessment. JAMA 2001; 286: 2815–22

    Article  PubMed  CAS  Google Scholar 

  31. Miller PD, Njeh CF, Jankowski LG, et al. What are the standards by which bone mass measurement at peripheral skeletal sites should be used in the diagnosis of osteoporosis? J Clin Densitom 2002; 5 Suppl.: S39–45

    Article  PubMed  Google Scholar 

  32. Binkley NC, Schmeer P, Wasnich RD, et al. What are the criteria by which a densitometric diagnosis of osteoporosis can be made in males and non-Caucasians? J Clin Densitom 2002; 5 Suppl.: S19–27

    Article  PubMed  Google Scholar 

  33. Kanis JA, Johnell O, Oden A, et al. Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies. Bone 2002; 30: 251–8

    Article  PubMed  CAS  Google Scholar 

  34. Kanis JA, Johnell O, Oden A, et al. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 2001; 12: 989–95

    Article  PubMed  CAS  Google Scholar 

  35. Berwick D. Developing and testing changes in delivery of care. Ann Intern Med 1998; 128: 651–6

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

No sources of funding were used to assist in manuscript preparation. The author has no conflicts of interest that are directly relevant to the contents of this article.

Author information

Authors and Affiliations

  1. Department of Rheumatology, Geisinger Clinic, Geisinger Health System, Danville, Pennsylvania, PA 17822-1341, USA

    Eric D. Newman (Director)

Authors
  1. Eric D. Newman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eric D. Newman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Newman, E.D. A Schema for Effective Osteoporosis Management. Dis-Manage-Health-Outcomes 11, 611–616 (2003). https://doi.org/10.2165/00115677-200311100-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00115677-200311100-00001

Keywords

Search

Navigation